Prévention de la maladie thromboembolique veineuse, chirurgie ambulatoire et nouveaux anticoagulants oraux directs

Gould, 2012, Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e227S, 10.1378/chest.11-2297 Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e278S, 10.1378/chest.11-2404 Samama, 2007, Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study, J Thromb Haemost, 5, 2360, 10.1111/j.1538-7836.2007.02779.x Jørgensen, 2013, Thromboprophylaxis only during hospitalisation in fast-track hip and knee arthroplasty, a prospective cohort study, BMJ Open, 3, e003965, 10.1136/bmjopen-2013-003965 Kim, 2015, Surgical duration and risk of venous thromboembolism, JAMA Surg, 150, 110, 10.1001/jamasurg.2014.1841 Engbæk, 2006, Return hospital visits and morbidity within 60 days after day surgery: a retrospective study of 18,736-day surgical procedures, Acta Anaesthesiol Scand, 50, 911, 10.1111/j.1399-6576.2006.01090.x Pannucci, 2012, Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery, Ann Surg, 255, 1093, 10.1097/SLA.0b013e3182519ccf Sweetland, 2009, Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study, BMJ Clin Res, 339, b4583, 10.1136/bmj.b4583 Levy, 2013, Managing new oral anticoagulants in the perioperative and intensive care unit setting, Anesthesiology, 118, 1466, 10.1097/ALN.0b013e318289bcba Eriksson, 2007, Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial, Lancet, 370, 949, 10.1016/S0140-6736(07)61445-7 Raskob, 2010, Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study, Thromb Haemostas, 104, 642, 10.1160/TH10-02-0142 Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med, 358, 2776, 10.1056/NEJMoa076016 Lassen, 2007, The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement, J Thromb Haemost, 5, 2368, 10.1111/j.1538-7836.2007.02764.x Cohen, 2013, Rivaroxaban for thromboprophylaxis in acutely ill medical patients, N Eng J Med, 368, 513, 10.1056/NEJMoa1111096 Faraoni, 2015, Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants, Crit Care, 19, 203, 10.1186/s13054-015-0930-9 Heidbuchel, 2013, European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation, Europace, 15, 625, 10.1093/europace/eut083 Samama, 2014, Pharmacology and laboratory testing of the oral Xa inhibitors, Clin Lab Med, 34, 503, 10.1016/j.cll.2014.06.009